Microcap Opportunities
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Portfolio Heats up to 42% Annual Return
The market heated up a bit in June and our MCO portfolio continues to do well.
Jul 11
•
Lindsay Leeds
1
Share this post
Microcap Opportunities
Portfolio Heats up to 42% Annual Return
Copy link
Facebook
Email
Notes
More
Why An Insider Just Made a Huge Purchase of NeurAxis Shares
We have featured several bullish articles and updates on NeurAxis (NRXS) in Microcap Opportunities. We continue to dig and find more to like about this…
Jul 6
•
Sergio Heiber
4
Share this post
Microcap Opportunities
Why An Insider Just Made a Huge Purchase of NeurAxis Shares
Copy link
Facebook
Email
Notes
More
2
June 2025
We Want To Be In Before the Bean Counters
End of the month review
Jun 29
•
Sergio Heiber
1
Share this post
Microcap Opportunities
We Want To Be In Before the Bean Counters
Copy link
Facebook
Email
Notes
More
NeurAxis (NRXS): A Steal at Current Market Price
I've been quietly watching NeurAxis (NRXS) develop its IB-Stim therapy for pediatric gastrointestinal disorders, and we're approaching an inflection…
Jun 23
•
Lindsay Leeds
and
Sergio Heiber
2
Share this post
Microcap Opportunities
NeurAxis (NRXS): A Steal at Current Market Price
Copy link
Facebook
Email
Notes
More
2
Taking Profits on Gossamer Bio
We added Gossamer Bio (GOSS) to our portfolio in September of last year at $0.91 per share.
Jun 22
•
Sergio Heiber
Share this post
Microcap Opportunities
Taking Profits on Gossamer Bio
Copy link
Facebook
Email
Notes
More
Testing Support and Gapology are in Play
An MCO Portfolio Technical Checkup
Jun 21
•
Sergio Heiber
Share this post
Microcap Opportunities
Testing Support and Gapology are in Play
Copy link
Facebook
Email
Notes
More
NeurAxis: A Vast Unrecognized Market Opportunity
NeurAxis (NYSE: NRXS) is executing its strategic plan.
Jun 15
•
Sergio Heiber
3
Share this post
Microcap Opportunities
NeurAxis: A Vast Unrecognized Market Opportunity
Copy link
Facebook
Email
Notes
More
1
The Steady Ascent of Aurora Spine: Is a Surge Coming?
Intro Aurora Spine recently reported its 2024 year-end results and subsequently its 2025 Q1 results.
Jun 9
•
Lindsay Leeds
3
Share this post
Microcap Opportunities
The Steady Ascent of Aurora Spine: Is a Surge Coming?
Copy link
Facebook
Email
Notes
More
Technical Analysis Should Not Be Overlooked
A technical review of the MicroCap Opportunity portfolio
Jun 8
•
Sergio Heiber
1
Share this post
Microcap Opportunities
Technical Analysis Should Not Be Overlooked
Copy link
Facebook
Email
Notes
More
1
How We Are Doing on Our Aim for 30% Annualized Return
Without further ado let’s break it down.
Jun 4
•
Lindsay Leeds
1
Share this post
Microcap Opportunities
How We Are Doing on Our Aim for 30% Annualized Return
Copy link
Facebook
Email
Notes
More
1
MicroCap Opportunities End of the Month Report - May 2025
I had the good fortune to shift my attention to microcap stocks in 2020 when potentially disruptive microcap stocks were in play.
Jun 1
•
Sergio Heiber
7
Share this post
Microcap Opportunities
MicroCap Opportunities End of the Month Report - May 2025
Copy link
Facebook
Email
Notes
More
4
May 2025
NeurAxis Investment Case
NeurAxis (NYSE: NRXS) is a neuromodulation medical technology company offering therapy based on its proprietary Percutaneous Electrical Nerve Field…
May 26
•
Sergio Heiber
1
Share this post
Microcap Opportunities
NeurAxis Investment Case
Copy link
Facebook
Email
Notes
More
5
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
